Bioavailability of plant pigment phytochemicals in angelica keiskei in older adults: A pilot absorption kinetic study

Nutrition Research and Practice

Volumn 8, Issue 5, 2014, Pages 550-557

  Correa, Camila R ^a,b   Oliver Chen, C Y ^a   Aldini, Giancarlo ^c   Rasmussen, Helen ^a   Ronchi, Carlos F ^a,b   Berchieri Ronchi, Carolina ^a,b   Cho, Soo Muk ^d   Blumberg, Jeffrey B ^a   Yeum, Kyung Jin ^e  

^a TUFTS UNIVERSITY   (United States)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF MILAN   (Italy)

^d National Institute of Animal Science   (South Korea)

^e Konkuk University   (South Korea)

Author keywords

Absorption kinetic; Angelica keiskei; Lutein; Quercetin; Total antioxidant performance

Indexed keywords

ANGELICA KEISKEI;

EID: 84908067231     PISSN: 19761457     EISSN: 20056168     Source Type: Journal    
DOI: 10.4162/nrp.2014.8.5.550     Document Type: Article

References (49)

1. Hata K, Kozawa M. Pharmacognostical studies on umbelliferous plants. XVIII. On the constituents of the roots of Angelica Keiskei Koidzumi. Yakugaku Zasshi 1961;81:1647-9.
2. Kozawa M, Morita N, Baba K, Hata K. Chemical components of the roots of Angelica keiskei Koidzumi. II. The structure of the chalcone derivatives (author's transl). Yakugaku Zasshi 1978;98:210-4.
3. Kozawa M, Morita N, Baba K, Hata K. Chemical components of the roots of Angelica keiskei Koidzumi. III. The structure of a new dihydrofurocoumarin (author's transl). Yakugaku Zasshi 1978;98: 636-8.
4. Motani K, Tabata K, Kimura Y, Okano S, Shibata Y, Abiko Y, Nagai H, Akihisa T, Suzuki T. Proteomic analysis of apoptosis induced by xanthoangelol, a major constituent of Angelica keiskei, in neuroblastoma. Biol Pharm Bull 2008;31:618-26.
5. Kimura Y. New anticancer agents: in vitro and in vivo evaluation of the antitumor and antimetastatic actions of various compounds isolated from medicinal plants. In Vivo 2005;19:37-60.
6. Akihisa T, Tokuda H, Hasegawa D, Ukiya M, Kimura Y, Enjo F, Suzuki T, Nishino H. Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects. J Nat Prod 2006;69:38-42.
7. Fujita T, Sakuma S, Sumiya T, Nishida H, Fujimoto Y, Baba K, Kozawa M. The effects of xanthoangelol E on arachidonic acid metabolism in the gastric antral mucosa and platelet of the rabbit. Res Commun Chem Pathol Pharmacol 1992;77:227-40.
8. Inamori Y, Baba K, Tsujibo H, Taniguchi M, Nakata K, Kozawa M. Antibacterial activity of two chalcones, xanthoangelol and 4-hydroxyderricin, isolated from the root of Angelica keiskei KOIDZUMI. Chem Pharm Bull (Tokyo) 1991;39:1604-5.
9. Kawabata K, Sawada K, Ikeda K, Fukuda I, Kawasaki K, Yamamoto N, Ashida H. Prenylated chalcones 4-hydroxyderricin and xanthoangelol stimulate glucose uptake in skeletal muscle cells by inducing GLUT4 translocation. Mol Nutr Food Res 2011;55:467-75.
10. Shimizu E, Hayashi A, Takahashi R, Aoyagi Y, Murakami T, Kimoto K. Effects of angiotensin I-converting enzyme inhibitor from Ashitaba (Angelica keiskei) on blood pressure of spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 1999;45:375-83.
11. Kang MH, Park YK, Kim HY, Kim TS. Green vegetable drink consumption protects peripheral lymphocytes DNA damage in Korean smokers. Biofactors 2004;22:245-7.
12. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005;81:243S-255S.
13. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005;81:230S-242S.
14. Aldini G, Regazzoni L, Pedretti A, Carini M, Cho SM, Park KM, Yeum KJ. An integrated high resolution mass spectrometric and informatics approach for the rapid identification of phenolics in plant extract. J Chromatogr A 2011;1218:2856-64.
15. Li L, Aldini G, Carini M, Oliver Chen CY, Chun HK, Cho SM, Park KM, Correa CR, Russell RM, Blumberg JB, Yeum KJ. Characterisation, extraction efficiency, stability and antioxidant activity of phytonutrients in Angelica keiskei. Food Chem 2009;115:227-32.
16. Yeum KJ, Aldini G, Chung HY, Krinsky NI, Russell RM. The activities of antioxidant nutrients in human plasma depend on the localization of attacking radical species. J Nutr 2003;133:2688-91.
17. Yeum KJ, Beretta G, Krinsky NI, Russell RM, Aldini G. Synergistic interactions of antioxidant nutrients in a biological model system. Nutrition 2009;25:839-46.
18. Aldini G, Yeum KJ, Russell RM, Krinsky NI. A method to measure the oxidizability of both the aqueous and lipid compartments of plasma. Free Radic Biol Med 2001;31:1043-50.
19. Beretta G, Aldini G, Facino RM, Russell RM, Krinsky NI, Yeum KJ. Total antioxidant performance: a validated fluorescence assay for the measurement of plasma oxidizability. Anal Biochem 2006; 354:290-8.
20. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004;27: 2444-9.
21. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report 2009:1-7.
22. Ford ES, Schulze MB, Pischon T, Bergmann MM, Joost HG, Boeing H. Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition- Potsdam Study. Cardiovasc Diabetol 2008;7:35.
23. Grundy SM. A constellation of complications: the metabolic syndrome. Clin Cornerstone 2005;7:36-45.
24. Malone DC, Boudreau DM, Nichols GA, Raebel MA, Fishman PA, Feldstein AC, Ben-Joseph RH, Okamoto LJ, Boscoe AN, Magid DJ. Association of cardiometabolic risk factors and prevalent cardiovascular events. Metab Syndr Relat Disord 2009;7:585-93.
25. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004;89:4963-71.
26. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003;52:2346-52.
27. Coyne T, Ibiebele TI, Baade PD, McClintock CS, Shaw JE. Metabolic syndrome and serum carotenoids: findings of a cross-sectional study in Queensland, Australia. Br J Nutr 2009;102:1668-77.
28. Zhao X, Aldini G, Johnson EJ, Rasmussen H, Kraemer K, Woolf H, Musaeus N, Krinsky NI, Russell RM, Yeum KJ. Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women. Am J Clin Nutr 2006;83:163-9.
29. Behrens WA, Madère R. A highly sensitive high-performance liquid chromatography method for the estimation of ascorbic and dehydroascorbic acid in tissues, biological fluids, and foods. Anal Biochem 1987;165:102-7.
30. Fossati P, Prencipe L, Berti G. Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 1980;26:227-31.
31. Chen CY, Milbury PE, Lapsley K, Blumberg JB. Flavonoids from almond skins are bioavailable and act synergistically with vitamins C and E to enhance hamster and human LDL resistance to oxidation. J Nutr 2005;135:1366-73.
32. Cho YS, Yeum KJ, Chen CY, Beretta G, Tang G, Krinsky NI, Yoon S, Lee-Kim YC, Blumberg JB, Russell RM. Phytonutrients affecting hydrophilic and lipophilic antioxidant activities in fruits, vegetables and legumes. J Sci Food Agric 2007;87:1096-107.
33. Zhang Z, Kou X, Fugal K, McLaughlin J. Comparison of HPLC methods for determination of anthocyanins and anthocyanidins in bilberry extracts. J Agric Food Chem 2004;52:688-91.
34. Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, D.C.: The National Academies Press; 2000.
35. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
36. Torres S, Salgado-Ceballos H, Torres JL, Orozco-Suarez S, Díaz-Ruíz A, Martínez A, Rivera-Cruz M, Ríos C, Lara A, Collado C, Guizar- Sahagún G. Early metabolic reactivation versus antioxidant therapy after a traumatic spinal cord injury in adult rats. Neuropathology 2010;30:36-43.
37. Montonen J, Knekt P, Järvinen R, Reunanen A. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 2004;27:362-6.
38. Graefe EU, Wittig J, Mueller S, Riethling AK, Uehleke B, Drewelow B, Pforte H, Jacobasch G, Derendorf H, Veit M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 2001;41:492-9.
39. Wiczkowski W, Romaszko J, Bucinski A, Szawara-Nowak D, Honke J, Zielinski H, Piskula MK. Quercetin from shallots (Allium cepa L. var. aggregatum) is more bioavailable than its glucosides. J Nutr 2008;138:885-8.
40. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010;328:228-31.
41. Dey A, Williams RS, Pollock DM, Stepp DW, Newman JW, Hammock BD, Imig JD. Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria. Obes Res 2004;12: 1278-89.
42. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-61.
43. van Het Hof KH, West CE, Weststrate JA, Hautvast JG. Dietary factors that affect the bioavailability of carotenoids. J Nutr 2000;130:503-6.
44. van den Berg H. Effect of lutein on beta-carotene absorption and cleavage. Int J Vitam Nutr Res 1998;68:360-5.
45. Kostic D, White WS, Olson JA. Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses. Am J Clin Nutr 1995;62:604-10.
46. Marisiddaiah R, Baskaran V. Bioefficacy of beta-carotene is improved in rats after solubilized as equimolar dose of beta-carotene and lutein in phospholipid-mixed micelles. Nutr Res 2009;29:588-95.
47. Talegawkar SA, Beretta G, Yeum KJ, Johnson EJ, Carithers TC, Taylor HA Jr, Russell RM, Tucker KL. Total antioxidant performance is associated with diet and serum antioxidants in participants of the diet and physical activity substudy of the Jackson Heart Study. J Nutr 2009;139:1964-71.
48. Dragsted LO, Pedersen A, Hermetter A, Basu S, Hansen M, Haren GR, Kall M, Breinholt V, Castenmiller JJ, Stagsted J, Jakobsen J, Skibsted L, Rasmussen SE, Loft S, Sandström B. The 6-a-day study: effects of fruit and vegetables on markers of oxidative stress and antioxidative defense in healthy nonsmokers. Am J Clin Nutr 2004;79:1060-72.
49. McKay DL, Chen CY, Yeum KJ, Matthan NR, Lichtenstein AH, Blumberg JB. Chronic and acute effects of walnuts on antioxidant capacity and nutritional status in humans: a randomized, cross-over pilot study. Nutr J 2010;9:21.